ORAGENICS, INC.
Income Statement
| Line Item | FY2010 |
|---|---|
| Revenue | $1.3M |
| Cost of Revenue | $911.8K |
| Gross Profit | $397.1K |
| Gross Margin | 30.3% |
| Operating Expenses | |
| Research & Development | $2.0M |
| SG&A Expense | $6.3M |
| Operating Income | $-7.9M |
| Operating Margin | -603.8% |
| Interest Expense | $33.9K |
| Pretax Income | $-8.5M |
| Income Tax Expense | $-733.4K |
| Net Income | $-7.8M |
| Net Margin | -596.3% |
| EPS (Basic) | $-0.14 |
| EPS (Diluted) | $-0.14 |
| Shares Outstanding (Basic) | 56.6M |
| Shares Outstanding (Diluted) | 56.6M |
| Dividends Per Share | — |